Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 5, 1996, Pages 536-544

  Bryan Lluka, Lesley J ^a   Seers, Hayley ^a   Sharpe, Iain ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Amezinium; Debrisoquine; Efflux; MAO A; Monoamine oxidase; Rat lungs; Uptake1

Indexed keywords

3',4' DIHYDROXY 2 METHYLPROPIOPHENONE; AMEZINIUM; CATECHOLAMINE METHYLTRANSFERASE INHIBITOR; DEBRISOQUINE; DESIPRAMINE; ISOPRENALINE; LAZABEMIDE; MONOAMINE OXIDASE B INHIBITOR; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PARGYLINE; RADIOISOTOPE; RESERPINE; UNCLASSIFIED DRUG;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE METABOLISM; CATECHOLAMINE RELEASE; CATECHOLAMINE UPTAKE; CONTROLLED STUDY; DEAMINATION; ENZYME INHIBITION; HEART PERFUSION; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATED LUNG; LUNG ENDOTHELIUM; LUNG PERFUSION; MALE; NONHUMAN; RAT; TISSUE SPECIFICITY;

EID: 0029939401     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00169173     Document Type: Article

References (28)

1. 3H-noradrenaline in isolated perfused rabbit hearts. Naunyn-Schmiedeberg's Arch Pharmacol 323: 233-244
2. Bryan LJ, Fleig H, Trendelenburg U (1983) A comparative study of the properties of the catechol-O-methyltransferase inhibitors. U-0521 and tropolone acetamide, in rat perfused heart. Naunyn-Schmiedeberg's Arch Pharmacol 322:6-19
3. Bryan LJ, O'Donnell SR, Williams AM (1986) The effects of thyroxine treatment of rats on neuronal and extraneuronal uptake and metabolism of catecholamines in the heart. Br J Pharmacol 87:337-344
4. Bryan-Lluka LJ (1993) Amezinium inhibits monoamine oxidase in endothelial cells of rat lungs. Clin Exp Pharmacol Physiol Suppl 1:10
5. Bryan-Lluka LJ, O'Donnell SR (1991) Isolated perfused lungs of guinea-pig, in contrast with rat, lack an uptake process for noradrenaline. Pulm Pharmacol 4:146-150
6. Bryan-Lluka LJ, O'Donnell SR (1992) Dopamine and adrenaline, but not isoprenaline, are substrates for uptake and metabolism in isolated perfused lungs of rats. Naunyn-Schmiedeberg's Arch Pharmacol 346:20-26
7. 1 in noradrenergic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 345:319-326
8. Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Saura Marti J, Muggli-Maniglio D, Wyss P-C, Kyburz E, Imhof R (1990) From moclobemide to Ro19-6327 and Ro41-1049:the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J Neural Transm Suppl 29:279-292
9. de la Lande IS, Parker DAS, Proctor CH, Marino V, Mackay-Sim A (1987) Cocaine inhibits extraneuronal O-methylation of exogenous norepinephrine in nasal and oral tissues of the rabbit. Life Sci 41:2463-2468
10. Edwards DJ, Pak KY, Venetti MC (1979) Developmental aspects of rat heart monoamine oxidase. Biochem Pharmacol 28:2337-2343
11. Graefe K-H, Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N (eds) Handbook of experimental pharmacology, 90:Catecholamines, vol I. Springer, Berlin Heidelberg New York, pp. 193-245
12. 3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147-1160
13. Grohmann M (1987) The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 336:139-147
14. Javors MA, Bembenek MF, Bowden CL, Abell CW, Maas JW (1989) The effect of debrisoquin on MAO A and MAO B activities. Life Sci 45:2359-2364
15. 3H-(-)-noradrenaline by rabbit endometrium. Naunyn-Schmiedeberg's Arch Pharmacol 336:148-154
16. 1:multifactorial induction of outward transport. Naunyn-Schmiedeberg's Arch Pharmacol 336:602-610
17. Lehmann HD, Dgiertz H, Kretschmar R, Lenke D, Philipsborn G, Raschack M, Schuster J (1981) Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects. Arzneim Forsch 31 [Suppl II]: 1544-1557
18. Lenke D, Gries J, Kretschmar R (1981) Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action. Arzneim Forsch 31 [Suppl II]: 1558-1565
19. 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS. peripheral organs, and human brain. J Neurosci 12:1977-1999
20. Scarcella DL, Bryan-Lluka LJ (1995) A kinetic investigation of the pulmonary metabolism of dopamine in rats shows marked differences compared with noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 351:491-499
21. Snedecor GW, Cochran WG (1989) Statistical methods. 8th edn. Iowa State University Press, Ames
22. Steppeler A, Starke K (1980) Selective inhibition by amezinium of intraneuronal monoamine oxidase. Naunyn-Schmiedeberg's Arch Pharmacol 314:13-16
23. 3H-amezinium in sympathetically innervated tissues. Naunyn-Schmiedeberg's Arch Pharmacol 316 [Suppl]:R55
24. Steppeler A, Pfändler RP, Hedler L, Starke K (1980) An analysis of the effects of amezinium on postganglionic sympathetic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 314:1-11
25. Traut M, Brode F, Hoffmann HD (1981) Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action. Arzneim-Forsch 31 [Suppl II]: 1566-1574
26. 3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 323:128-140
27. Westwood NN, Bryan-Lluka LJ (1993) Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats. J Pharmacol Exp Ther 267:815-821
28. 1-mediated efflux of catecholamines from pulmonary endothelial cells of perfused lungs of rats. Naunyn-Schmiedeberg's Arch Pharmacol 353:528-535